{"symbol": "GLMD", "companyName": "Galmed Pharmaceuticals Ltd.", "exchange": "NASDAQ Capital Market", "industry": "Biotechnology", "website": "http://www.galmedpharma.com", "description": "Galmed Pharmaceuticals Ltd is a clinical-stage biopharmaceutical company. It is engaged in the development and commercialization of oral therapy for the treatment of liver diseases and cholesterol gallstones.", "CEO": "Allen Baharaff", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}